Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date. [electronic resource]
Producer: 20151228Description: 586-618 p. digitalISSN:- 1098-1128
- Animals
- Antineoplastic Agents -- chemistry
- Drug Design
- Drug Screening Assays, Antitumor
- Epigenesis, Genetic
- Gene Expression Regulation, Leukemic
- Histone Demethylases -- chemistry
- Humans
- Inhibitory Concentration 50
- Leukemia, Myeloid, Acute -- drug therapy
- Lysine -- chemistry
- Mice
- Polyamines -- chemistry
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.